Literature DB >> 9859970

Simian T-lymphotropic virus type I infection among wild-caught Indonesian pig-tailed macaques (Macaca nemestrina).

A L Richards1, A Giri, D Iskandriati, J Pamungkas, A Sie, L Rosen, R L Anthony, G Franchini.   

Abstract

Evidence for the presence of simian T-lymphotropic viruses (STLV-I) was identified in live-caught pig-tailed macaques from two locations in southern Sumatra, Indonesia. Of 60 animals tested, 13.3% of the animals showed seroreactivity to HTLV-I/II enzyme-linked immunosorbent assay (ELISA) antigens. Of these, 75% showed indeterminate reactivity and 25% showed positive reactivity to HTLV-I/II Western blot antigens. Polymerase chain reaction (PCR) analysis of 6 of 8 seroreactive monkeys' peripheral blood mononuclear cell (PBMC) DNA showed production of proper size molecular weight product that hybridized specifically to an STLV-I tax gene-specific probe. Phylogenic analyses of tax gene fragment sequences from the PCR products of two samples, 930287 and 930306, indicated that these animals were infected with retroviruses related to those of the Asian STLV-I clade.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9859970     DOI: 10.1097/00042560-199812150-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  3 in total

1.  The infectious diseases consequences of monkey business.

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

2.  Divergent simian T-cell lymphotropic virus type 3 (STLV-3) in wild-caught Papio hamadryas papio from Senegal: widespread distribution of STLV-3 in Africa.

Authors:  Laurent Meertens; Antoine Gessain
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Temple monkeys and health implications of commensalism, Kathmandu, Nepal.

Authors:  Lisa Jones-Engel; Gregory A Engel; John Heidrich; Mukesh Chalise; Narayan Poudel; Raphael Viscidi; Peter A Barry; Jonathan S Allan; Richard Grant; Randy Kyes
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.